Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
cloBAZam
cloBAZam
- Formulary
- Non-formulary Miscellaneous Programs
Last updated: Jun. 28, 2022
- Black Box Warning: Risk From Concomitant Use with Opioids
- HAZ-MED: Group 3
- Formulary, Not Routinely Stocked: Onfi --> 20 mg tablet
Onfi tablet and oral suspension medication guide
ONFI is approved as a formulary agent. Previously, only the 5 mg tablet was routinely stocked. However, the 5 mg tablet is no longer available and the 10 mg will be stocked in its place (9/3/2013).
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
clobazam buccal film (Sympazan)
clobazam (Onfi)
Sympazan is classified as non-formulary. Patients on Sympazan should be converted to Onfi tablets or suspension, whichever is best appropriate, through a therapeutic interchange at a one-to-one ratio.
Inpatients may use their own supply if necessary.
Reviewed: February 28, 2012, July 2020 (Sympazan)